PCR-amplified tRNA gene (tDNA) intergenic spacer length polymorphism (tDNA-ILP) was analyzed for its ability to identify to the species level type strains (n ‫؍‬ 18) and clinical isolates (n ‫؍‬ 163) of staphylococci. Amplified products obtained by PCR with outwardly directed consensus tDNA primers were separated by agarose and polyacrylamide gel electrophoreses. The results were compared with those obtained by biochemical identification and ribotyping. Each type strain presented a specific tDNA-ILP pattern. PCR with fluorescent primers allowed for the detection of labelled DNA fragments on polyacrylamide gels by using an automated laser fluorescence sequencer and provided enhanced pattern resolution in comparison with that by analysis on agarose gels. tDNA patterns indistinguishable from those of the type strains were produced by clinical isolates of all tested species except for some isolates of S. aureus (n ‫؍‬ 3) and S. haemolyticus (n ‫؍‬ 1), which showed variant patterns. Strains of S. saprophyticus and S. xylosus showed very closely related profiles, and S. cohnii subspecies were indistinguishable. The identities obtained by tDNA-ILP analysis agreed with those obtained by the biochemical method to the species level for 99% (162 of 163) of the strains tested and to the subspecies level for 96% (156 of 163) of the strains tested. These results indicate that fluorescence-labelled PCR analysis of tDNA-ILP provides an accurate and rapid molecular method for the identification of human staphylococci.
Whereas the pathogenicity of Staphylococcus aureus has long been established, coagulase-negative staphylococci (CoNS) are increasingly recognized as etiologic agents of infections of soft tissue, indwelling foreign bodies, and the bloodstream in humans (10, 11, 14, 23) . The use of implanted medical devices such as intravascular catheters and the growing number of immunocompromised patients contribute to the increasing importance of CoNS as causes of nosocomial infections (4, 16) . Particular species of CoNS are associated with distinct types of infections and patterns of antimicrobial susceptibility (10, 22) . Therefore, identification of clinical isolates to the species level is increasingly of clinical and epidemiological interest.
Among the 32 species currently recognized in the genus Staphylococcus (7), isolates of coagulase-negative species that are commonly recovered from clinical specimens include S. epidermidis, followed by S. haemolyticus and S. hominis. S. saprophyticus is commonly associated with community-acquired urinary tract infections (10) . Isolates of more recently described species, including S. warneri, S. lugdunensis, S. capitis, and S. schleiferi, are occasionally recovered from clinical specimens (7, 9, 10, 22) . Among these species, S. lugdunensis appears to be of particular virulence, notably as a cause of destructive endocarditis (23) . CoNS are conventionally identified in the clinical laboratory by using biochemical identification systems which have accuracies ranging between 60 and 98% (1, 7, 9) . Molecular biology-based methods that enable characterization of staphylococci to the species level include total genomic DNA-DNA hybridization, ribotyping analysis (24) , and hybridization of genomic DNA to labelled probes specific for hypervariable sequences of the gene encoding the heat shock protein (3). Another strategy for bacterial identification which shows considerable promise is PCR analysis of length polymorphism of the intergenic spacers lying between tRNA genes (12, 26, 27) . Because tRNA genes contain sequence motifs that are highly conserved among the eubacteria, consensus tRNA gene primers can be designed to explore the amount of tRNA gene intergenic length polymorphism (tDNA-ILP) between species (26) .
The objective of this study was to evaluate the performance of PCR analysis of tRNA intergenic spacer polymorphism for the differentiation of staphylococcal type strains as well as for the identification of clinical isolates of diverse origins belonging to 15 species reported as human commensals and pathogens.
MATERIALS AND METHODS
Bacterial strains. The type strains of the genus Staphylococcus (n ϭ 18) used in this study are listed in Table 1 . The strains were kindly provided by the Centre National de Référence des Staphylocoques (Lyon, France).
Clinical isolates collected from blood, urine, and wound specimens in four Belgian hospitals during the period from 1988 to 1995 included S. epidermidis (n ϭ 32) and S. saprophyticus (n ϭ 15), with each isolate showing different major SmaI pulsed-field gel electrophoresis types; S. haemolyticus (n ϭ 13); S. hominis (n ϭ 23); S. lugdunensis (n ϭ 11); S. schleiferi (n ϭ 6); S. capitis subsp. ureolyticus (n ϭ 15); S. warneri (n ϭ 7); and S. simulans (n ϭ 3). Methicillin-resistant (n ϭ 15) and -susceptible (n ϭ 23) S. aureus clinical isolates showing various SmaI pulsed-field gel electrophoresis types were selected from an international collection and included isolates from four European countries including Belgium (19) and from a previous collection (20) (1988 to 1993) .
Phenotypic characterization. Clinical isolates of CoNS (n ϭ 125) were identified by the ID 32 Staph system (BioMérieux, Marcy l'Etoile, France), which was used according to the manufacturer's instructions, and by the use of the APILAB ID 32 software (version 2.2.7, 1994). Coagulase activity was detected with human plasma after 4 and 24 h to identify S. aureus isolates. The identification of S. saprophyticus isolates was confirmed by xylose fermentation and the novobiocin (Rosco Diatabs, Taastrup, Denmark) susceptibility test.
Oxacillin susceptibility. Oxacillin agar screening (Becton Dickinson, Sparks, Md.) was performed according to National Committee for Clinical Laboratory Standards guidelines.
Ribotyping. Ribotyping was performed by using EcoRI endonuclease, as described previously (24) .
tDNA-ILP PCR. Genomic DNA was prepared by the rapid lysis procedure described by Ü nal et al. (21) . PCR was carried out with outwardly directed tRNA gene (tDNA) consensus primers T5A (5Ј-GTCCGGTGCTCTAACCAACT GAG) and T3B (5Ј-AGGTCGCGGGTTCGAATCC) described by Welsh and McClelland (27) . Fifty microliters of PCR solution contained 1.25 U of Taq polymerase (Cetus Corp., Emeryville, Calif.), 1ϫ PCR buffer (50 mM KCl, 10 mM Tris-HCl [pH 8.3]), 1.5 mM MgCl 2 , 0.5 M (each) primer, 0.2 mM each of the four deoxynucleoside triphosphates, and 5 l of the bacterial lysate as the DNA template. The reaction mixture was overlaid with 1 drop of mineral oil. Amplification conditions were as described previously (27) .
Analysis of tDNA-ILP by agarose gel electrophoresis. The products of amplification were separated by electrophoresis for 3 h and 30 min at 160 V in a 4% Metaphor agarose gel (FMC BioProducts, Zellik, Belgium) supplemented with ethidium bromide (0.25 mg/ml) in Tris-Borate-EDTA buffer (pH 8.3). The size marker pBR322 HaeIII digest (Sigma, Bornem, Belgium) contains DNA fragments of between 8 and 587 bp. The patterns of the amplified products were visually compared and codified by using a capital letter with arabic numerals. The arabic numerals indicate the number of different fragments in comparison with the of fragments of the reference strains.
Analysis of tDNA-ILP by using the ALFexpress (Automated Laser Fluorescent) DNA sequencer. tDNA-ILP was analyzed by using the ALFexpress DNA sequencer (Pharmacia Biotech, Roosendaal, The Netherlands). Primer T5B was 5Ј end labelled with Cy5 during the synthesis (Pharmacia). The amplification products were separated by electrophoresis through 6% (wt/vol) acrylamidebisacrylamide-7 M urea denaturating gels (ReadyMix Gel, A.L.F. grade; Pharmacia) in 1ϫ TBE (Tris-borate-EDTA) buffer. A fluorescein-labelled molecular size marker (Cy5 Sizer 50-500; Pharmacia), including 10 fragments ranging in size from 50 to 500 bp, was used as an external size ladder. The samples, including 2 l of the PCR products, 5 l of gel loading solution (Pharmacia), and 0.4 l of each of the internal reference standards of 100 and 1,064 bp (5), were denatured at 95°C for 2 min and loaded onto the gel. Electrophoretic separation was done at 1,500 V, 60 mA, and 15 W for 4 h at 40°C. Internal and external markers were compared by using the Software Fragment Manager (Pharmacia) to normalize the gel. The fluorescence densitograms were visually compared, and digitized fluorescence data were exported to and analyzed with the GelCompar software (Applied Maths, Kortrijk, Belgium) by using Pearson correlation coefficients.
RESULTS
The tDNA-ILP patterns of the type strains of 15 Staphylococcus species and 4 (among 6) subspecies showed different banding patterns by agarose electrophoresis (Fig. 1) . Each pattern consisted of 8 to 11 DNA fragments ranging in size from approximately 60 to 600 bp. The tDNA-ILP patterns distinguished most of the species by a number of specific DNA fragments. The patterns of S. saprophyticus and S. xylosus differed only by a single fragment that showed a small difference in size (Fig. 1, lanes 13 and 18) . The type strains of the two subspecies of S. cohnii were indistinguishable (Fig. 1, lanes 6  and 7) , whereas the subspecies of S. capitis and S. schleiferi showed distinctive patterns (Fig. 1, lanes 4 iment as well as in separate PCR experiments and analyzed on the same gel, showed complete reproducibility.
As indicated in Table 1 , all clinical strains of S. epidermidis, S. capitis subsp. ureolyticus, S. lugdunensis, S. saprophyticus, S. schleiferi, S. simulans, and S. warneri showed tDNA-ILP patterns that were identical to those of the type strain. Thirty-five of the 38 clinical isolates of S. aureus had a banding pattern identical to that of the S. aureus type strain. Three S. aureus isolates showed patterns with one fragment (n ϭ 2) or two fragments (n ϭ 1) in addition to the fragments in the core pattern of S. aureus CCM 885, but the patterns were clearly different from the patterns exhibited by other species. The clinical strains of S. haemolyticus (n ϭ 13) were assigned to the same tDNA-ILP type as S. haemolyticus CCM 2737, but one strain had a pattern that was different by two fragments from the pattern of the type strain, but the pattern was also different from those of all the other type strains by several fragments (Fig. 2, lane 12) .
Some discrepancies between the results of phenotypic identification and those of tDNA-ILP analysis-based identification were observed. To resolve these discrepancies, identification by means of ribotyping (24) was done for 25 clinical isolates for which no definite identification at the species level could be obtained (n ϭ 21) or for which biochemical identification and tDNA-ILP analysis-based identification were in disagreement (n ϭ 4). For two isolates discrepancies between identities by tDNA-ILP analysis and with the ID 32 Staph system were found ( Table 2) . These two isolates, identified by the ID 32 Staph system as S. warneri and S. epidermidis, respectively, exhibited ribotype patterns and tDNA-ILP patterns identical to those of S. capitis subsp. ureolyticus and S. hominis, respectively. Except for subspecies characterization of S. schleiferi, results from tDNA-ILP analysis and ribotyping were in complete agreement ( Table 2 ). The single S. hominis isolate that showed an unknown tDNA-ILP fingerprint also could not be classified by ribotyping when its ribotype pattern was compared to the ribotype patterns of 32 described species. Overall, the results of tDNA-ILP analysis were in agreement with those of biochemical identification complemented with ribotyping analysis to the species level for 99% (162 of 163) of the clinical isolates of 10 species tested and to the subspecies level for 96% (156 of 163) of the subspecies tested.
ALFexpress analysis of tDNA-ILP patterns was performed with all type strains and 85 clinical isolates belonging to 10 species. The densitometric curves generated by amplified products from clinical isolates appeared highly conserved within a species ( Fig. 3 and 4) . Visual comparison of the densitometric curves provided by the ALFexpress system was considerably easier than visual of the patterns exhibited on agarose gels (Fig. 1, 3 , and 4). were 92 and 84% for S. epidermidis and S. hominis, respectively.
DISCUSSION
Differentiating clinically significant isolates of CoNS from the contaminating flora is a daily issue in clinical bacteriology. Identification to the species level of isolates from independent specimens is helpful in achieving this aim. Phenotypic methods often do not allow for the correct identification of all clinical isolates of CoNS (7, 8, 13, 15, 18) . For example, S. hominis, one of the most common species after S. epidermidis and S. haemolyticus, was identified with low accuracy by the API ID 32 Staph system (Biomérieux) (7) and the Staph-Ident system (Biomérieux) (1) . Recently, a number of molecular biologybased approaches to the identification of species of clinically important bacteria have been described. Widjojoatmodjo et al. (28) proposed a general approach based on single-strand conformation polymorphism analysis of PCR-amplified 16S rRNA gene fragments. A disadvantage of this method is the use in the PCR amplification of conserved primers that can be hampered by contamination of reagents with exogenous bacterial DNA. Another method, called amplified ribosomal DNA restriction analysis, has been reported to discriminate between bacteria in different genera to the species level (25) . However, compared to tDNA-ILP analysis, several restrictions may be needed to obtain a final discrimination between species. Also, restriction fragment length polymorphism analysis of the amplified 16S rRNA gene is unable to differentiate between most Staphylococcus species (24a) .
PCR analysis of the length polymorphism of the intergenic spacers lying between 16S and 23S rRNA genes (6) or between tRNA genes (2, 27) is useful for identifying microorganisms to the species level. The initial description of tRNA-ILP analysis was applied to a limited number of species of staphylococci (27) . We evaluated more extensively the usefulness of tDNA-PCR for the identification of these microorganisms in the study described in this report. Except for S. aureus and S. haemolyticus, which both exhibited minor intraspecific variations, a remarkable level of conservation of tDNA-ILPs was seen within each species. Because the clinical isolates were selected as being epidemiologically nonrelated, these findings indicated a high degree of intraspecies stability of the organization of tRNA genes in staphylococci, thereby supporting the concept that the organization of tRNA genes changes very slowly. On the other hand, the extensive interspecies diversity reported here indicates that tDNA-ILP analysis can be used with a high degree of specificity as a tool for the rapid identification of human staphylococci. The usefulness of the method was confirmed by comparison of the results with those of ribotyping in cases in which biochemical identification either proved inconclusive or the pattern by biochemical identification was at variance with the tDNA-ILP pattern. Overall, the accuracy of the tDNA-ILP analysis method was 99% for the identification of clinical isolates belonging to 10 staphylococcal species.
Accurate and reproducible identification by this novel molecular biology-based method critically depends on correct analysis of the sizes of the PCR products. Analysis of fragment patterns by electrophoresis at 160 V for 3 h and 30 min in a 4% Metaphor agarose gel showed the best resolving power for products of Յ1 kb. Although pattern reproducibility was good, the resolution of the electrophoretic profiles was occasionally affected by minor variations in the porosity of the agarose. The use of a more accurate method of post-PCR analysis with an automated laser fluorescence sequencer (ALFexpress; Pharmacia) showed excellent intraspecies reproducibility of the tDNA-ILP patterns and discrimination between the 15 species of staphylococci by computer-assisted analysis (Fig. 5 ).
An interesting concordance was found between the clustering based on tDNA-ILP analysis and that based on DNA-DNA homology classification (17) . A first group comprised S. hominis and S. haemolyticus (70% related by tDNA-ILP analysis and 45% related by DNA-DNA hybridization). A second group included the species S. capitis, S. caprae, S. epidermidis, and S. warneri (more than 65% related by tDNA-ILP analysis and about 40% related by DNA-DNA hybridization). S. xylosus, S. saprophyticus, and S. cohnii formed a third cluster (more than 70% related by tDNA-ILP analysis and about 40% related by DNA-DNA hybridization). This suggests that tDNA-ILP analysis reflects phylogenetic taxonomy in a manner comparable to that of DNA homology determination.
In summary, tDNA-ILP analysis exhibited 99% accuracy for the identification of staphylococcal isolates encountered in a clinical laboratory within 9 h of obtaining a pure culture. Fluorescent DNA fragment analysis provided with higher-resolution software-based pattern interpretation allowed for the rapid and accurate comparison of patterns and species identification. Further clinical evaluation should define the optimal use of tDNA-ILP analysis either as a confirmatory test or as a first-line identification method in the laboratory.
